Thiazide-induced hypercalcemia in vitamin D-treated hypoparathyroidism.
D000328:Adult; D000368:Aged; D001539:Bendroflumethiazide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002118:Calcium / Q000097:blood / Q000652:urine; D002740:Chlorothiazide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004487:Edema / Q000188:drug therapy; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced*; D006973:Hypertension / Q000188:drug therapy; D007011:Hypoparathyroidism / Q000188:drug therapy*; D008736:Methyclothiazide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D012964:Sodium / Q000652:urine; D014807:Vitamin D / Q000627:therapeutic use
D014807:Vitamin D; D001539:Bendroflumethiazide; D002740:Chlorothiazide; D012964:Sodium; D008736:Methyclothiazide; D002118:Calcium